分子与组织学特征不同的低级别胶质瘤切除程度及其对生存影响的体积对比分析
该回顾性队列纳入2005至2015年间由单一位外科医生手术的109例成人低级别胶质瘤患者,通过MRI体积计算评估切除程度并检测IDH1、1p/19q共缺失和p53等分子标志物。中位切除程度为88.1%,术后永久性神经功能缺损发生率为4.6%。切除程度是总生存和无进展生存的显著预测因素,1p/19q共缺失可预测恶性进展无进展生存。
要点
- 中位切除程度为88.1%,术后永久性神经功能缺损发生率为4.6%。
- 切除程度是总生存(HR=0.979)和无进展生存(HR=0.982)的显著预测因素。
- 1p/19q共缺失可预测恶性进展无进展生存(HR=0.148)。
核心结论
- 增加切除程度与总生存和无进展生存改善相关,而1p/19q共缺失与恶性进展无进展生存改善相关。
- 理解手术切除程度和肿瘤分子标志物对低级别胶质瘤患者的有效管理均很重要。
研究设计与样本
- 回顾性队列研究,纳入2005年至2015年间由单一位外科医生手术的109例成人低级别胶质瘤患者。
- 通过MRI体积计算评估切除程度,并评估IDH1、1p/19q共缺失和p53等分子标志物对生存和神经功能结局的影响。
主要发现
- 中位切除程度为88.1%,术后永久性神经功能缺损发生率为4.6%。
- 切除程度是总生存的显著预测因素(HR=0.979,95% CI 0.961-0.980,p=0.029)。
- 切除程度是无进展生存的显著预测因素(HR=0.982,95% CI 0.968-0.997,p=0.018)。
- 1p/19q共缺失可预测恶性进展无进展生存(HR=0.148,95% CI 0.019-1.148,p=0.048)。
- 切除程度100%的患者总生存显著优于切除程度小于90%者(p=0.038);切除程度至少76%的患者总生存优于小于76%者(p=0.025);切除程度至少71%的患者无进展生存优于小于71%者(p=0.030)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The authors investigate the role of extent of resection (EOR) and genetic markers on patient outcome and survival for LGGs. We conducted a retrospective cohort between 2005 and 2015, of 109 adult patients who underwent surgery for a LGG by a single surgeon. Volumetric computations of MRI studies were conducted to evaluate the EOR, and genetic markers (IDH1, 1p/19q co-deletion, and p53) were assessed and their effects on survival and neurological outcome were evaluated. The median EOR was 88.1%. Permanent postoperative neurological deficits were seen in 4.6% of patients. EOR was a significant predictor for both overall survival (OS) (hazard ratio [HR] = 0.979, 95% CI 0.961-0.980, p = 0.029) and progression free survival (PFS) (HR = 0.982, 95% CI 0.968-0.997, p = 0.018). Malignant progression free survival (MPFS) was predicted by the 1p/19q co-deletion (HR = 0.148, 95% CI 0.019-1.148, p = 0.048). Patients with EOR of 100% had a significantly better OS than EOR less than 90% (p = 0.038). Patients with an EOR of at least 76% had a better OS than EOR less than 76% (p = 0.025). Patients with an EOR of at least 71% had a better PFS than EOR less than 71% (p = 0.030). Preoperative tumor volume was found to have significant association with EOR (R2 = 0.049, p = 0.031). Increased EOR is associated with improved OS and PFS survival outcomes, while 1p/19q co-deletion provides improved MPFS. Understanding both surgical resections and molecular markers of the tumor are important for effective management of LGG patients.
引用
- Eseonu CI, Eguia F, ReFaey K, et al. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival. J Neurooncol. 2017. PMID: 28527004. doi:10.1007/s11060-017-2486-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。